Bretton Capital Management LLC Invests $5.73 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Bretton Capital Management LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 9,800 shares of the healthcare conglomerate’s stock, valued at approximately $5,730,000. UnitedHealth Group comprises approximately 5.5% of Bretton Capital Management LLC’s investment portfolio, making the stock its 6th biggest holding.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Vanguard Group Inc. raised its stake in shares of UnitedHealth Group by 0.6% during the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after buying an additional 544,740 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after acquiring an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after purchasing an additional 35,533 shares during the last quarter. International Assets Investment Management LLC increased its holdings in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on UNH. Argus boosted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Truist Financial restated a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. KeyCorp initiated coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. Finally, UBS Group decreased their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Down 1.4 %

UNH opened at $605.88 on Thursday. The stock has a market cap of $557.58 billion, a PE ratio of 39.47, a price-to-earnings-growth ratio of 1.80 and a beta of 0.58. The stock’s fifty day simple moving average is $582.99 and its 200 day simple moving average is $548.03. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the firm earned $6.56 EPS. The business’s revenue was up 9.2% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.